JP Morgan Raises PT on Hartford Insurance to $142, Maintains Neutral Rating.
ByAinvest
Tuesday, Jul 29, 2025 12:03 pm ET1min read
FDS--
The Hartford Insurance Group reported a Q2 adjusted earnings per share (EPS) of $3.41, surpassing the FactSet estimate of $2.83. The company's Q2 revenue also rose to $6.99 billion, slightly missing the FactSet estimate of $7.04 billion [3]. This performance has led to a positive reassessment of the company's stock value by JPMorgan.
The latest price target adjustment follows a series of changes from other major financial institutions. Notably, Wells Fargo raised its price target to $138 from $134, maintaining an overweight rating [2]. Similarly, UBS increased its target to $145 from $142, keeping a buy rating [2]. These adjustments reflect a growing optimism among analysts regarding The Hartford's financial health and future prospects.
The changes in price targets come amidst a broader trend of uncertainty in the healthcare sector, particularly concerning the Affordable Care Act (ACA) [2]. Despite this, The Hartford's strong Q2 results and the company's leading market share in Medicaid have bolstered investor confidence [2].
The Hartford Insurance Group continues to navigate a dynamic market landscape, with recent executive changes and equity buyback plans aimed at enhancing shareholder value. The appointment of Thomas Bartlett as a director further underscores the company's commitment to strategic leadership [1].
References:
[1] https://www.marketscreener.com/news/jpmorgan-adjusts-price-target-on-hartford-insurance-group-to-142-from-140-maintains-neutral-ratin-ce7c5fd9dc8ff124
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3TQ08X:0-jp-morgan-trims-pt-on-centene-and-molina-citing-aca-uncertainties/
[3] https://www.tradingview.com/news/reuters.com,2025-07-28:newsml_PLX11C5CC:0-brief-hartford-insurance-group-q2-core-eps-usd-3-41-vs-ibes-estimate-usd-2-83/
FISI--
HIG--
JPM--
WFC--
JP Morgan Raises PT on Hartford Insurance to $142, Maintains Neutral Rating.
JPMorgan has adjusted its price target on The Hartford Insurance Group, Inc. (HIG) to $142, maintaining a neutral rating. This decision comes following the company's strong Q2 earnings report, which saw a surge in profit due to increased insurance demand and investment income [3].The Hartford Insurance Group reported a Q2 adjusted earnings per share (EPS) of $3.41, surpassing the FactSet estimate of $2.83. The company's Q2 revenue also rose to $6.99 billion, slightly missing the FactSet estimate of $7.04 billion [3]. This performance has led to a positive reassessment of the company's stock value by JPMorgan.
The latest price target adjustment follows a series of changes from other major financial institutions. Notably, Wells Fargo raised its price target to $138 from $134, maintaining an overweight rating [2]. Similarly, UBS increased its target to $145 from $142, keeping a buy rating [2]. These adjustments reflect a growing optimism among analysts regarding The Hartford's financial health and future prospects.
The changes in price targets come amidst a broader trend of uncertainty in the healthcare sector, particularly concerning the Affordable Care Act (ACA) [2]. Despite this, The Hartford's strong Q2 results and the company's leading market share in Medicaid have bolstered investor confidence [2].
The Hartford Insurance Group continues to navigate a dynamic market landscape, with recent executive changes and equity buyback plans aimed at enhancing shareholder value. The appointment of Thomas Bartlett as a director further underscores the company's commitment to strategic leadership [1].
References:
[1] https://www.marketscreener.com/news/jpmorgan-adjusts-price-target-on-hartford-insurance-group-to-142-from-140-maintains-neutral-ratin-ce7c5fd9dc8ff124
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3TQ08X:0-jp-morgan-trims-pt-on-centene-and-molina-citing-aca-uncertainties/
[3] https://www.tradingview.com/news/reuters.com,2025-07-28:newsml_PLX11C5CC:0-brief-hartford-insurance-group-q2-core-eps-usd-3-41-vs-ibes-estimate-usd-2-83/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet